PTIX Protagenic Therapeutics, Inc.

NASDAQ
$0.77

Protagenic Therapeutics, Inc. (PTIX) is expected to report earnings on November 18, 2026, after the market close.

Protagenic Therapeutics Reported Earnings
Wednesday, August 19, 2026 · 12:00 AM ET
Earnings Date
Nov 18
Wednesday · After Close
Earnings Whisper
-
vs -
Volatility
Enter your expectations below to reveal the current volatility.
Trend Analysis
Expectation
Earnings
Price action
Signals
Score
Sentiment
Grade
Life Cycle
Call Analysis
Earnings-AVWAP -

Sign in or subscribe to unlock sentiment, short interest, and technical indicators.

About Protagenic Therapeutics, Inc.

Protagenic Therapeutics, Inc. is a biotechnology company. It focused on the discovery, research and development of novel and naturally occurring human brain hormones for the treatment of anxiety and depression based mood disorders. Protagenic Therapeutics, Inc., formerly known as Atrinsic, Inc., is based in New York, United States.

Sector

Healthcare

Industry

Biotechnology

Charts powered in part by Lightweight Charts™ by TradingView.